What is THORASYS?
THORASYS is a leading technology firm recognized for its expertise in respiratory diagnostics, particularly through its proprietary Airwave Oscillometry System (AOS). As a global frontrunner in oscillometry innovation, Thorasys is committed to advancing respiratory healthcare with cutting-edge solutions. The company's focus on scientific rigor and industrial excellence aims to set new global benchmarks for respiratory diagnostics, with its technologies deployed in clinical settings and research trials.
How much funding has THORASYS raised?
THORASYS has raised a total of $1.3M across 1 funding round:
Private Equity
$1.3M
Private Equity (2016): $1.3M with participation from Anges Quebec
Key Investors in THORASYS
Anges Quebec
Anges Québec is a Canadian angel investor network that supports innovative projects with capital and strategic guidance. They focus on technology entrepreneurs and have a history of investing in companies aiming for local and international growth.
What's next for THORASYS?
The substantial enterprise-level backing and recent strategic investment position THORASYS for significant expansion and technological advancement. This capital infusion is anticipated to fuel further research and development into novel respiratory diagnostic tools, enhance market penetration, and potentially explore new therapeutic applications. The company's trajectory suggests a focus on solidifying its leadership in the global respiratory diagnostics market and driving innovation in patient care.
See full THORASYS company page
